Q754Q7 AF NFT

Oligosaccharide translocation protein RFT1

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeihryfv7n74dqyfiszamc7xxjavwfnnsrr33yzwgvll5pd75v2zbgy/metadata.json
IPFS of structure file: 
bafybeigxtk6hxznldc5uofzso7m5ixebaabqhs5zsjrfjp4kl7r6ileflu/AF-Q754Q7-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x166774432Fa02840CA63277F9d861DcB92479204
First NFT owner address (bech32): 
genesis1zenhgse05q5ypjnryalempsaewfy0ysyzq6y2u
Current NFT ID #341359 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
341359
Accession (UniProt):
Q754Q7
Name::
Oligosaccharide translocation protein RFT1
Experimental Method:
Predicted structure
Sequence source:
ASHBYA GOSSYPII (STRAIN ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q754Q7 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q754Q7|RFT1_ASHGO Oligosaccharide translocation protein RFT1 OS=Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=RFT1 PE=3 SV=1 MCSTGEEILAKSTQGATFLMMGQLFGKLVTFVLHNVLVRFLSPRIFGITSFLDFLSSTVLFFSREAIRLATLRIKTGGDGGRGGEMSAELQTAVNFANIPMCIGAPLAVVLAVWQYSNLNSYFTQLPFFSWSIYLVLLSILAELASEPLYVVNQFMLNYRKRSQFEGAAVAASCLVNFAVIYWYENWVNGRGETVHDSYKQEGIAVLAFALGKVARAMTLLALYYVDYVRHLAHEKLFSLSLTKVRVPGSVYTAYFDSDVLQHFKKVYFQLCFKHLLTEGDKLIINSLCTVEEQGIYSLLSNYGSLITRMVFAPIEESLLLFLTRLLSDKTQQNLHICMRVLVNLVKFYLYLALVIVIFGPTNSSFLLKFLIGSKWSSTSVLETIRVYCFYLPFLSMNGILEAFFASVASGDEILRHSYLMMLLSGVFLLNCWVFLAHFNLSLEGLIFSNIINMTLRIIYCSNYIRGFYKRLFADSKQTSLSSSFAGLKKILLLCIVVAYVDWSIIGYVQNIRQLLVNILLSVTLVLAMAYNERKLLLEFIKKSKPVPVKEN